A Concerted Redox‐ and Light‐Activated Agent for Controlled Multimodal Therapy against Hypoxic Cancer Cells
Open Access
- 22 March 2023
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 35 (19) , e2210363
Abstract
Hypoxia represents a remarkably exploitable target for cancer therapy, is encountered only in solid human tumors, and is highly associated with cancer resistance and recurrence. Here, a hypoxia‐activated mitochondria‐accumulated Ru(II) polypyridyl prodrug functionalized with conjugated azo (Az) and nitrogen mustard (NM) functionalities, RuAzNM, is reported. This prodrug has multimodal theranostic properties toward hypoxic cancer cells. Reduction of the azo group in hypoxic cell microenvironments gives rise to the generation of two primary amine products, a free aniline mustard, and the polypyridyl RuNH 2 complex. Thus, the aniline mustard triggers generation of reactive oxygen species (ROS) and mtDNA crosslinking. Meanwhile, the resultant biologically benign phosphorescent RuNH 2 gives rise to a diagnostic signal and signals activation of the phototherapy. This multimodal therapeutic effect eventually elevates ROS levels, depletes reduced nicotinamide adenine dinucleotide (NADH) and adenosine triphosphate (ATP), and induces mitochondrial membrane damage, mtDNA damage, and ultimately cell apoptosis. This unique strategy allows controlled multimodal theranostics to be realized in hypoxic cells and multicellular spheroids, making RuAzNM a highly selective and effective cancer‐cell‐selective theranostic agent (IC 50 = 2.3 µ m for hypoxic HepG2 cancer cells vs 58.2 µ m for normoxic THL‐3 normal cells). This is the first report of a metal‐based compound developed as a multimodal theranostic agent for hypoxia.Keywords
Funding Information
- Natural Science Foundation of Guangdong Province (2020A1515011153)
- Engineering and Physical Sciences Research Council (EP/P030572/1)
- Engineering and Physical Sciences Research Council (EP/T021675)
- Engineering and Physical Sciences Research Council (EP/V006746)
- Engineering and Physical Sciences Research Council (RPG‐2020‐208)
- Engineering and Physical Sciences Research Council (EP/V007688/1)
This publication has 47 references indexed in Scilit:
- Chemical Genetics Analysis of an Aniline Mustard Anticancer Agent Reveals Complex I of the Electron Transport Chain as a TargetJournal of Biological Chemistry, 2011
- Targeting hypoxia in cancer therapyNature Reviews Cancer, 2011
- Hypoxia-Sensitive Fluorescent Probes for in Vivo Real-Time Fluorescence Imaging of Acute IschemiaJournal of the American Chemical Society, 2010
- Ultrafast Dynamics of the Low-Lying 3MLCT States of [Ru(bpy)2(dppp2)]2+Journal of the American Chemical Society, 2010
- Ultrafast Electron Localization Dynamics Following Photo-Induced Charge TransferScience, 2000
- Prodrugs of anticancer agentsAdvanced Drug Delivery Reviews, 1996
- Reductase Enzyme Expression Across the National Cancer Institute Tumor Cell Line Panel: Correlation With Sensitivity to Mitomycin C and EO9JNCI: Journal of the National Cancer Institute, 1996
- The Mechanism of Microsomal Azoreduction: Predictions Based on Electronic Aspects of Structure-Activity RelationshipsDrug Metabolism Reviews, 1995
- A new mixing of Hartree–Fock and local density-functional theoriesThe Journal of Chemical Physics, 1993
- Development of the Colle-Salvetti correlation-energy formula into a functional of the electron densityPhysical Review B, 1988